(Q37538736)

20 August 2017

1 reference

title

Artificial pancreas: an emerging approach to treat Type 1 diabetes (English)

1 reference

20 August 2017

0 references

0 references

Mark L Evans

2

0 references

Roman Hovorka

object named as

Roman Hovorka

series ordinal

3

0 references

author name string

Kavita Kumareswaran

series ordinal

1

1 reference

20 August 2017

1 July 2009

1 reference

Expert Review of Medical Devices

20 August 2017

1 reference

20 August 2017

6

1 reference

20 August 2017

4

1 reference

20 August 2017

401-410

1 reference

Incidence of childhood type 1 diabetes worldwide. Diabetes Mondiale (DiaMond) Project Group

20 August 2017

1 reference

Incidence and trends of childhood Type 1 diabetes worldwide 1990-1999.

21 January 2018

1 reference

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

21 January 2018

1 reference

Are insulin pumps underutilized in type 1 diabetes? Yes.

21 January 2018

1 reference

Determinants of glycaemic control in type 1 diabetes during intensified therapy with multiple daily insulin injections or continuous subcutaneous insulin infusion: importance of blood glucose variability

21 January 2018

1 reference

Continuous subcutaneous insulin infusion (CSII) 30 years later: still the best option for insulin therapy

21 January 2018

1 reference

Glycaemic control with continuous subcutaneous insulin infusion compared with intensive insulin injections in patients with type 1 diabetes: meta-analysis of randomised controlled trials

21 January 2018

1 reference

Long-acting insulin analogs versus insulin pump therapy for the treatment of type 1 and type 2 diabetes

21 January 2018

1 reference

External and implantable insulin pumps: current place in the treatment of diabetes

21 January 2018

1 reference

Implantable closed-loop glucose-sensing and insulin delivery: the future for insulin pump therapy

21 January 2018

1 reference

Implantable insulin pumps. A position statement about their clinical use.

21 January 2018

1 reference

Combined improvements in implantable pump technology and insulin stability allow safe and effective long term intraperitoneal insulin delivery in type 1 diabetic patients: the EVADIAC experience.

21 January 2018

1 reference

Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen

21 January 2018

1 reference

Five-year follow-up after clinical islet transplantation

21 January 2018

1 reference

Cell-based treatments for diabetes

21 January 2018

1 reference

The future of open- and closed-loop insulin delivery systems

21 January 2018

1 reference

Evaluating clinical accuracy of systems for self-monitoring of blood glucose

21 January 2018

1 reference

Comparison of the numerical and clinical accuracy of four continuous glucose monitors

21 January 2018

1 reference

Evaluating the accuracy of continuous glucose-monitoring sensors: continuous glucose-error grid analysis illustrated by TheraSense Freestyle Navigator data

21 January 2018

1 reference

Performance assessment of the Medtronic-MiniMed Continuous Glucose Monitoring System and its use for measurement of glycaemic control in Type 1 diabetic subjects

21 January 2018

1 reference

Relationship of fasting and hourly blood glucose levels to HbA1c values: safety, accuracy, and improvements in glucose profiles obtained using a 7-day continuous glucose sensor

21 January 2018

1 reference

The accuracy of the FreeStyle Navigator continuous glucose monitoring system in children with type 1 diabetes

21 January 2018

1 reference

Clinical application of emerging sensor technologies in diabetes management: consensus guidelines for continuous glucose monitoring (CGM).

21 January 2018

1 reference

Continuous glucose monitoring and intensive treatment of type 1 diabetes

21 January 2018

1 reference

Sensor-augmented insulin pump therapy: results of the first randomized treat-to-target study

21 January 2018

1 reference

The future of continuous glucose monitoring: closed loop

21 January 2018

1 reference

Response to nocturnal alarms using a real-time glucose sensor

21 January 2018

1 reference

A critical assessment of algorithms and challenges in the development of a closed-loop artificial pancreas

21 January 2018

1 reference

Closed-loop insulin delivery-the path to physiological glucose control

21 January 2018

1 reference

Nonlinear model predictive control of glucose concentration in subjects with type 1 diabetes.

21 January 2018

1 reference

On-line adaptive algorithm with glucose prediction capacity for subcutaneous closed loop control of glucose: evaluation under fasting conditions in patients with Type 1 diabetes.

21 January 2018

1 reference

Detection of a meal using continuous glucose monitoring: implications for an artificial beta-cell

21 January 2018

1 reference

Continuous glucose monitoring and closed-loop systems

21 January 2018

1 reference

A direct comparison of insulin aspart and insulin lispro in patients with type 1 diabetes

21 January 2018

1 reference

An Artificial Endocrine Pancreas

21 January 2018

1 reference

Devices for insulin administration

21 January 2018

1 reference

Modeling beta-cell insulin secretion--implications for closed-loop glucose homeostasis

21 January 2018

1 reference

Evaluation of the effect of gain on the meal response of an automated closed-loop insulin delivery system

21 January 2018

1 reference

Feasibility of automating insulin delivery for the treatment of type 1 diabetes

21 January 2018

1 reference

Fully automated closed-loop insulin delivery versus semiautomated hybrid control in pediatric patients with type 1 diabetes using an artificial pancreas

21 January 2018

1 reference

Closing the loop: the adicol experience

21 January 2018

1 reference

Preventing hypoglycemia using predictive alarm algorithms and insulin pump suspension

21 January 2018

1 reference

Continuous subcutaneous insulin infusion with short-acting insulin analogues or human regular insulin: efficacy, safety, quality of life, and cost-effectiveness

21 January 2018

1 reference

Quantifying the impact of a short-interval interruption of insulin-pump infusion sets on glycemic excursions

21 January 2018

1 reference

Pharmacodynamics and stability of subcutaneously infused glucagon in a type 1 diabetic Swine model in vivo.

21 January 2018

1 reference

The human amylin analog, pramlintide, reduces postprandial hyperglucagonemia in patients with type 2 diabetes mellitus

21 January 2018

1 reference

The role of amylin and glucagon in the dampening of glycemic excursions in children with type 1 diabetes

21 January 2018

1 reference

Evaluation of glucose controllers in virtual environment: methodology and sample application

21 January 2018

1 reference

Meal simulation model of the glucose-insulin system

21 January 2018

1 reference

Clinical validation of a new control-oriented model of insulin and glucose dynamics in subjects with type 1 diabetes.

21 January 2018

1 reference

Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: a prospective study

21 January 2018

1 reference

Intensive insulin therapy in critically ill patients

21 January 2018

1 reference

Benefits and risks of tight glucose control in critically ill adults: a meta-analysis

21 January 2018

1 reference

Intensive versus conventional glucose control in critically ill patients

21 January 2018

1 reference

Closed-loop glucose control in critically ill patients using continuous glucose monitoring system (CGMS) in real time

21 January 2018

1 reference

Multicentric, randomized, controlled trial to evaluate blood glucose control by the model predictive control algorithm versus routine glucose management protocols in intensive care unit patients

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1586/ERD.09.23

1 reference

20 August 2017

1 reference

PubMed ID

19572795